Cargando…

Measurement of Circulating Tumor Cells to Track Hepatocellular Carcinoma Progression After Liver Transplantation-Case Report

Management of patients with hepatocellular carcinoma (HCC) largely relies on surgery and other systemic therapies. However, the poor diagnosis of cancer recurrence or metastasis can lead to a high frequency of treatment failure. Thus, factors that can predict disease status and prognosis of patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Deng, Yuan, Sun, Lei, Liang, Heng, Cui, Bojing, Cui, Caimei, Zhao, Dan, Wan, Arabella, Wan, Guohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565924/ https://www.ncbi.nlm.nih.gov/pubmed/34745999 http://dx.doi.org/10.3389/fonc.2021.760765

Ejemplares similares

Research progress of circulating non-coding RNA in diagnosis and treatment of hepatocellular carcinoma
por: You, Junqi, et al.
Publicado: (2023)

Ischemic-Free Liver Transplantation Reduces the Recurrence of Hepatocellular Carcinoma After Liver Transplantation
por: Tang, Yunhua, et al.
Publicado: (2021)

Association of Preoperative NANOG-Positive Circulating Tumor Cell Levels With Recurrence of Hepatocellular Carcinoma
por: Lei, Yongrong, et al.
Publicado: (2021)

Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?
por: Gonvers, Stéphanie, et al.
Publicado: (2022)

Long Noncoding RNA AC007639.1 Promotes the Pathogenesis and Progression of Hepatocellular Carcinoma Through Inhibiting Apoptosis and Stimulating Chemotherapeutic Resistance
por: Bai, Yun, et al.
Publicado: (2021)

Liver Transplantation Versus Liver Resection for Stage I and II Hepatocellular Carcinoma: Results of an Instrumental Variable Analysis
por: Li, Wei, et al.
Publicado: (2021)

Prognostic Factors for 10-Year Survival in Patients With Hepatocellular Cancer Receiving Liver Transplantation
por: Lai, Quirino, et al.
Publicado: (2022)

Erratum: Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?
Publicado: (2023)

Research progress on circulating tumor cells of hepatocellular carcinoma
por: Wan, Chenyu, et al.
Publicado: (2021)

Pulmonary Resection for Metastasis of Hepatocellular Carcinoma Recurring After Liver Transplant: An Italian Multicenter Experience
por: Invenizzi, Federica, et al.
Publicado: (2020)

Seminal vesicle mass: An unusual site for metastatic hepatocellular carcinoma after orthotopic liver transplant
por: Aponte-Colon, Diana A., et al.
Publicado: (2021)

Endothelial angiopoietin-2 overexpression in explanted livers identifies subjects at higher risk of recurrence of hepatocellular carcinoma after liver transplantation
por: Lasagni, Simone, et al.
Publicado: (2022)

Mitochondrial Quality Control in Hepatocellular Carcinoma
por: Bian, Jinda, et al.
Publicado: (2021)

Clinical applications of circulating tumor cells in hepatocellular carcinoma
por: Hua, Yinggang, et al.
Publicado: (2022)

Efficacy and safety of transarterial chemoembolization plus sorafenib in patients with recurrent hepatocellular carcinoma after liver transplantation
por: Zhang, Xia, et al.
Publicado: (2023)

Impact of Graft Weight Change During Perfusion on Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation
por: Kim, Jong Man, et al.
Publicado: (2021)

Association between vessels that encapsulate tumour clusters vascular pattern and hepatocellular carcinoma recurrence following liver transplantation
por: Dennis, Claude, et al.
Publicado: (2022)

Research progress of targeted therapy combined with immunotherapy for hepatocellular carcinoma
por: Xie, Shuqi, et al.
Publicado: (2023)

The upregulation of CLGN in hepatocellular carcinoma is potentially regulated by hsa-miR-194-3p and associated with patient progression
por: Cui, Zhongyuan, et al.
Publicado: (2023)

Diagnosis of rapidly progressed primary cardiac lymphoma in liver transplant recipient: A case report
por: Li, Jianghua, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Current Progresses and Challenges
por: Liu, Hao-Tian, et al.
Publicado: (2021)

Clinical prognosis of intraoperative blood salvage autotransfusion in liver transplantation for hepatocellular carcinoma: A systematic review and meta-analysis
por: Wang, Zheng, et al.
Publicado: (2022)

Thermal ablation as an alternative to liver transplantation for hepatocellular carcinoma with clinically significant portal hypertension: propensity score matching study
por: Long, Yinglin, et al.
Publicado: (2023)

Methyladenosine Modification in RNAs: Classification and Roles in Gastrointestinal Cancers
por: Li, Qinghai, et al.
Publicado: (2021)

Progress of MRI Radiomics in Hepatocellular Carcinoma
por: Gong, Xue-Qin, et al.
Publicado: (2021)

New Liver MR Imaging Hallmarks for Small Hepatocellular Carcinoma Screening and Diagnosing in High-Risk Patients
por: Gao, Feifei, et al.
Publicado: (2022)

Long-Term Surgical Outcomes of Liver Resection for Hepatocellular Carcinoma in Patients With HBV and HCV Co-Infection: A Multicenter Observational Study
por: Jia, Hang-Dong, et al.
Publicado: (2021)

A comprehensive comparison of circulating tumor cells and breast imaging modalities as screening tools for breast cancer in Chinese women
por: Shao, Xuan, et al.
Publicado: (2022)

Impact of type 2 diabetes mellitus on the prognosis of patients with hepatocellular carcinoma after laparoscopic liver resection: A multicenter retrospective study
por: Yang, Shi-Ye, et al.
Publicado: (2022)

Effect of Severity of Liver Cirrhosis on Surgical Outcomes of Hepatocellular Carcinoma After Liver Resection and Microwave Coagulation
por: Li, Jiang, et al.
Publicado: (2021)

Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma
por: Chen, Jing, et al.
Publicado: (2022)

Does liver resection/transplantation affect respiratory induced liver motion in patients with hepatocellular carcinoma?
por: Hu, Yong, et al.
Publicado: (2017)

Tumor genomic profiling and personalized tracking of circulating tumor DNA in Vietnamese colorectal cancer patients
por: Nguyen, Huu Thinh, et al.
Publicado: (2022)

Research Progress of DUB Enzyme in Hepatocellular Carcinoma
por: Zhao, Jie, et al.
Publicado: (2022)

Identification of Key Circulating Exosomal microRNAs in Gastric Cancer
por: Qian, Xiaoqing, et al.
Publicado: (2021)

The Presence of Circulating Tumor Cell Cluster Characterizes an Aggressive Hepatocellular Carcinoma Subtype
por: Yu, Jing-Jing, et al.
Publicado: (2021)

Circulating messenger RNA variants as a potential biomarker for surveillance of hepatocellular carcinoma
por: Block, Timothy, et al.
Publicado: (2022)

Systemic therapies in hepatocellular carcinoma: Existing and emerging biomarkers for treatment response
por: He, Penghui, et al.
Publicado: (2022)

Survival After Treatable Hepatocellular Carcinoma Recurrence in Liver Recipients: A Nationwide Cohort Analysis
por: Ho, Cheng-Maw, et al.
Publicado: (2021)

Liver transplantation in gastroenteropancreatic neuroendocrine tumors
por: Fernandes, Eduardo de Souza M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v8bg4ojjg0ucsndtfsosgm6c38